Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Camurus Oy
OY
Active
Y-tunnus 2864875-7
Uudenmaankatu 1-5, 00120
Helsinki
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2017 · 8 years old
3 employees
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
Camurus Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
763
663
685
685
814
Staff expenses
−307
−320
−0
−0
−459
EBITDA
53
56
61
53
66
Depreciation & amort.
—
—
−0
−0
−0
EBIT
53
56
61
53
66
Net financials
−0
−0
1
6
8
Profit before tax
53
56
62
59
74
Tax
11
8
14
13
16
Net profit
42
48
49
46
58
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
324
411
478
555
642
Equity
153
201
0
0
353
Long-term debt
—
—
0
0
0
Short-term debt
170
210
9
19
32
Total debt
170
210
228
260
289
Financial ratios
5-year trend
EBITDA margin
8.1%
This company
15.8%
Market median
-49% vs market
2021
2025
Equity ratio
55.0%
This company
38.2%
Market median
+44% vs market
2021
2025
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
2021
2025
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
2021
2025
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
2021
2025
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Camurus Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network